EDITORIAL
Published on 03 May 2023
Editorial: Cardio-oncology: mechanisms and therapeutics
doi 10.3389/fcvm.2023.1198617
- 1,080 views
- Frontiers in Cardiovascular Medicine
- Cardio-Oncology
- Research Topics
- Cardio-Oncology: Mechanisms and therapeutics
Cardio-Oncology: Mechanisms and therapeutics
43k
Total downloads
153k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 07 Feb 2023
Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network
doi 10.3389/fcvm.2023.888366
- 3,926 views
ORIGINAL RESEARCH
Published on 05 Jan 2023
Impact of genetically predicted atrial fibrillation on cancer risks: A large cardio-oncology Mendelian randomization study using UK biobank
doi 10.3389/fcvm.2022.974402
- 2,091 views
- 7 citations
REVIEW
Published on 08 Nov 2022
Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis
doi 10.3389/fcvm.2022.966182
- 5,251 views
- 14 citations
ORIGINAL RESEARCH
Published on 19 Oct 2022
Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
doi 10.3389/fcvm.2022.901431
- 1,473 views
- 5 citations
ORIGINAL RESEARCH
Published on 23 Sep 2022
Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?
doi 10.3389/fcvm.2022.922095
- 1,651 views
- 1 citation
REVIEW
Published on 23 Sep 2022
Cardiovascular disease and chimeric antigen receptor cellular therapy
doi 10.3389/fcvm.2022.932347
- 3,224 views
- 6 citations
MINI REVIEW
Published on 21 Sep 2022
Cardiovascular effects of immunosuppression agents
doi 10.3389/fcvm.2022.981838
- 10,164 views
- 32 citations
ORIGINAL RESEARCH
Published on 14 Sep 2022
The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
doi 10.3389/fcvm.2022.960240
- 1,425 views
- 5 citations
ORIGINAL RESEARCH
Published on 08 Sep 2022
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
doi 10.3389/fcvm.2022.930797
- 3,193 views
- 29 citations
ORIGINAL RESEARCH
Published on 12 Aug 2022
Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study
doi 10.3389/fcvm.2022.922811
- 1,303 views
- 4 citations
CASE REPORT
Published on 23 Jun 2022
Case Report: Unusual Cause of Chest Pain: A Multi-Image Assessment of a Cardiac Mass
doi 10.3389/fcvm.2022.889406
- 1,407 views
Published in
Frontiers in Cardiovascular Medicine
- Cardio-Oncology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 153kTopic views
- 108kArticle views
- 43kArticle downloads